| SUMMARY OF WARRANT ACTIVITY |
The
following table summarizes warrant activity for the nine months ended March 31, 2026:
SUMMARY OF WARRANT ACTIVITY
| | |
| | |
Weighted | |
| | |
Number of | | |
Average | |
| | |
Warrants | | |
Price Per Share | |
| Outstanding at June 30, 2025 | |
| 10 | | |
$ | 15,000.00 | |
| Granted – Common stock warrants | |
| 1,200 | | |
| 100.00 | |
| Granted – Series C preferred stock warrants | |
| 9,900 | | |
| 10,000 | |
| Exercised – Series C preferred stock warrants | |
| (100 | ) | |
| 10,000 | |
| Forfeited | |
| - | | |
| - | |
| Expired | |
| - | | |
| - | |
| Outstanding at March 31, 2026 | |
| 11,010 | | |
$ | 8,925.52 | |
| | |
| | | |
| | |
| Exercisable at March 31, 2026 | |
| 11,010 | | |
$ | 8,925.52 | |
| Outstanding and Exercisable: | |
| | | |
| | |
| | |
| | | |
| | |
| Weighted average remaining contractual term | |
| 3.67 | | |
| | |
| Aggregate intrinsic value | |
$ | - | | |
| | |
|
The
following table summarizes common stock warrant activity for the years ended June 30, 2025 and 2024:
SUMMARY OF WARRANT ACTIVITY
| | |
| | |
Weighted | |
| | |
Number of | | |
Average | |
| | |
Warrants | | |
Price
Per Share | |
| Outstanding at June 30, 2023 | |
| - | | |
$ | 8,160,000,000 | |
| Issued | |
| 10 | | |
| 15,000 | |
| Exercised | |
| - | | |
| - | |
| Forfeited | |
| - | | |
| - | |
| Expired | |
| - | | |
| - | |
| Outstanding at June 30, 2024 | |
| 10 | | |
$ | 31.00 | |
| Issued | |
| - | | |
| - | |
| Exercised | |
| - | | |
| - | |
| Cancelled* | |
| - | | |
| - | |
| Expired | |
| - | | |
| - | |
| Outstanding at June 30, 2025 | |
| 10 | | |
$ | 0.25 | |
| | |
| | | |
| | |
| Exercisable at June 30, 2025 | |
| 10 | | |
$ | 0.25 | |
| Outstanding and Exercisable: | |
| | | |
| | |
| | |
| | | |
| | |
| Weighted average remaining contractual term | |
| 1.01 | | |
| | |
| Aggregate intrinsic value | |
$ | 1,035 | | |
| | |
|
* |
On
March 3, 2025, the Company cancelled all the existing warrants (de minimis number of shares of Series A warrants, Series B warrants,
and Series C warrants) held by an investor pursuant to a Warrant Exchange Agreement (see above). |
|
| SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS ACTIVITY |
A
summary of the Company’s option activity during the nine months ended March 31, 2026 is presented below:
SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS ACTIVITY
| | |
| | |
Weighted | |
| | |
Number of | | |
Average Exercise | |
| | |
Shares | | |
Price Per Share | |
| Outstanding at June 30, 2025 | |
| nil | | |
$ | 6,800,000,000,000 | |
| Granted | |
| - | | |
| - | |
| Exercised | |
| - | | |
| - | |
| Forfeited | |
| - | | |
| - | |
| Expired | |
| - | | |
| - | |
| Outstanding at March 31, 2026 | |
| nil | | |
$ | 6,800,000,000,000 | |
| | |
| | | |
| | |
| Exercisable at March 31, 2026 | |
| nil | | |
$ | 6,800,000,000,000 | |
| Outstanding and Exercisable: | |
| | | |
| | |
| | |
| | | |
| | |
| Weighted average remaining contractual term | |
| 3.12 | | |
| | |
| Weighted average fair value of options granted during the period | |
$ | - | | |
| | |
| Aggregate intrinsic value | |
$ | - | | |
| | |
|
A
summary of the Company’s stock option activity during the years ended June 30, 2025 and 2024 is presented below:
SCHEDULE OF SHARE BASED COMPENSATION STOCK OPTIONS ACTIVITY
| | |
| | |
Weighted | |
| | |
Number of | | |
Average | |
| | |
Options | | |
Price
Per Share | |
| Outstanding at June 30, 2023 | |
| nil | | |
$ | 6,800,000,000,000 | |
| Issued | |
| - | | |
| - | |
| Exercised | |
| - | | |
| - | |
| Expired | |
| - | | |
| - | |
| Outstanding at June 30, 2024 | |
| nil | | |
$ | 6,800,000,000,000 | |
| Issued | |
| - | | |
| - | |
| Exercised | |
| - | | |
| - | |
| Expired | |
| - | | |
| - | |
| Outstanding at June 30, 2025 | |
| nil | | |
$ | 6,800,000,000,000 | |
| | |
| | | |
| | |
| Exercisable at June 30, 2025 | |
| nil | | |
$ | 6,800,000,000,000 | |
| Outstanding and Exercisable: | |
| | | |
| | |
| | |
| | | |
| | |
| Weighted average remaining contractual term | |
| 3.87 | | |
| | |
| Weighted average fair
value of options granted during the year | |
$ | - | | |
| | |
| Aggregate intrinsic value | |
$ | - | | |
| | |
|